Sir Dave Brailsford suggests Team Sky are looking to make all TUEs public
Sir Dave Brailsford says he has trust in the TUE system and says Team Sky are looking into the possibility of making all TUEs public
- (opens in new tab)
- (opens in new tab)
- (opens in new tab)
- Sign up to our newsletter Newsletter

Sir Dave Brailsford has defended Team Sky's use of therapeutic usage exemptions (TUE), and said that his team are looking to make the process completely transparent by making all TUE information public
Sky and former rider Sir Bradley Wiggins have come under fire in recent weeks after hackers released details of his previous TUEs, as well as those of Chris Froome.
Wiggins's six exemptions included three for the intra-muscular injection of corticosteroid triamcinolone before the Tours de France in 2011 and 12, and the Giro d'Italia in 2013, which was used to treat allergies and was signed off by the UCI.
There is no suggestion of wrongdoing by any of the parties involved, but Brailsford defended the ethical nature of the process, saying he has complete trust and believe in the integrity of it.
The Team Sky manager went further to say that his team is looking at making all TUE information available to the public in future, if his riders consent.
"On one hand you've got the people who would like to know what is going on against the contrast of medical confidentiality," Brailsford told Sky News. (opens in new tab)
"I think in there is a balance. We've reviewed this over the years and we've changed our policy, we've changed the way we do it and going forward I think we are going to take the next step which is being debated on a wider basis to look at, with the consent of the riders, making all TUEs transparent."
He added: "You ask yourself the question: if a rider needs a TUE you can either make it public so everyone knows they have a TUE, or they don't compete. I think that's the way this whole debate is heading. These records are supposed to be confidential, but they're not."
Self-confessed dopers such as David Millar and Michael Rasmussen have claimed in the last weeks that the triamcinolone drug that was prescribed to Wiggins acts as a powerful weight-loss drug.
Talking to the BBC, Brailsford confirmed that he was aware of what Wiggins was taking at the time and insisted the medication was not administered to enhance performance.
"I have known Bradley a long time and he is an asthma sufferer and he has struggled with allergies for as long as I have known him," Brailsford said.
"I know that at the time there was a recommendation to see a specialist, he went to see a specialist and was then given permission by the authorities.
"I trust and believe in the integrity of that process."
Thank you for reading 10 articles this month* Join now for unlimited access
Enjoy your first month for just £1 / $1 / €1
*Read 5 free articles per month without a subscription
Join now for unlimited access
Try first month for just £1 / $1 / €1
Stuart Clarke is a News Associates trained journalist who has worked for the likes of the British Olympic Associate, British Rowing and the England and Wales Cricket Board, and of course Cycling Weekly. His work at Cycling Weekly has focused upon professional racing, following the World Tour races and its characters.
-
-
Developing great bike racers and good people - Jonathan Vaughters and Rusty Miller have big goals for the EF Education-ONTO junior program
In partnering with the ONTO Junior Racing Program, EF Education becomes the only WorldTour program with a junior team.
By Jessica Alexander • Published
-
Wout van Aert v. Mathieu van der Poel - a truly rare and iconic sporting rivalry
As the duo continue to trade blows on the biggest of stages, their rivalry will go down in history as one of cycle racings greatest
By Tom Thewlis • Published
-
Global backers in talks over new British WorldTour team
Former management of Ribble Weldtite courting interest in new project
By Tom Thewlis • Published
-
'I remember the crowds more than anything': Tom Pidcock recalls his Alpe d'Huez Tour de France stage win
Our male rider of the year, Tom Pidcock, talks us through the highs and lows of his 2022 campaign
By Tom Thewlis • Published
-
Leo Hayter, Cycling Weekly's rising star of 2022, talks through his season in the spotlight
We caught up with the winner of the "Baby Giro" to hear all about the win in Italy and his dream move to Ineos Grenadiers
By Tom Thewlis • Published
-
Ineos Grenadiers release 'visibly fast' 2023 jersey
Navy is replaced with red as British team changes its look
By Adam Becket • Published
-
Where next for Mark Cavendish after B & B Hotels-KTM's collapse?
We look at where the ‘Manx Missile’ could find himself next after the collapse of B & B Hotels-KTM
By Tom Thewlis • Published
-
‘It’s a good thing and shows progression of the sport’ - Ben Swift hails changes at British Cycling academy
Ineos Grenadier says putting academy riders in with development teams will encourage development of many skills
By Tom Thewlis • Published
-
'I know I can do it so I need to make that next level': Ben Turner signs Ineos Grenadiers contract extension
The Classics and another Grand Tour are on the agenda for Doncaster's Big Ben
By Chris Marshall-Bell • Published
-
Tom Pidcock unsure whether he will defend cyclocross world title in 2023
“I don’t know yet, crossing in the winter and being good in the classics is a difficult combination” Pidcock said
By Tom Thewlis • Published